Seasonal superoxide overproduction and endothelial activation in guinea-pig heart; seasonal oxidative stress in rats and humans

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 4, 2011, Pages 686-694

  Konior, Anna ^a   Klemenska, Emilia ^a   Brudek, Magdalena ^b   Podolecka, Ewa ^a   Czarnowska, Elzbieta ^b   Beresewicz, Andrzej ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Endothelial NO synthase; NADPH oxidase; Oxidative stress; Seasonality; Superoxide dismutase; Xanthine oxidase

Indexed keywords

8 ISOPROSTANE; CELL ADHESION MOLECULE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVITY; FEMALE; GLYCOCALYX; GUINEA PIG; HEART; HEART PERFUSION; HUMAN; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RODENT; SEASONAL VARIATION; SPRING; STREPTOZOCIN DIABETES; SUMMER; UPREGULATION; URINARY EXCRETION;

ANIMALS; BLOTTING, WESTERN; DINOPROST; ENDOTHELIUM, VASCULAR; FEMALE; GLYCOCALYX; GUINEA PIGS; HEART; HUMANS; MALE; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SEASONS; SUPEROXIDES; VASODILATION; XANTHINE OXIDASE;

CAVIA; RATTUS; RODENTIA;

EID: 79952067682     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.11.010     Document Type: Article

References (42)

1. Li J.M., Shah A.M. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol 2004, 287:R1014-R1030.
2. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1378-1381.
3. Harrison D.G., Widder J., Grumbach I., Chen W., Weber M., Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 2006, 259:351-363.
4. Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006, 113:1708-1714.
5. Giannotti G., Landmesser U. Endothelial dysfunction as an early sign of atherosclerosis. Herz 2007, 32:568-572.
6. Widlansky M.E., Vita J.A., Keyes M.J., Larson M.G., Hamburg N.M., Levy D., et al. Relation of season and temperature to endothelium-dependent flow-mediated vasodilation in subjects without clinical evidence of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 2007, 100:518-523.
7. Nawrot T.S., Staessen J.A., Fagard R.H., Van Bortel L.M., Struijker-Boudier H.A. Endothelial function and outdoor temperature. Eur J Epidemiol 2005, 20:407-410.
8. Klein-Weigel P., Krall K., Falkensammer J., Heinz-Erian P., Ulmer H., Fraedrich G. Lack of seasonal variation in flow-mediated dilatation of the brachial artery in women with primary Raynaud's phenomenon and healthy controls. Vasa 2003, 32:69-73.
9. Morera A.L., Intxausti A., Abreu-Gonzalez P. Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research. World J Biol Psychiatry 2008, 5:1-5.
10. Bello-Klein A., Morgan-Martins M.I., Barp J., Llesuy S., Bello A.A., Singal P.K. Circaannual changes in antioxidants and oxidative stress in the heart and liver in rats. Comp Biochem Physiol C Toxicol Pharmacol 2000, 126:203-208.
11. Mujkosova J., Ferko M., Humenik P., Waczulikova I., Ziegelhoffer A. Seasonal variations in properties of healthy and diabetic rat heart mitochondria: Mg2+-ATPase activity, content of conjugated dienes and membrane fluidity. Physiol Res 2008, 57(Suppl 2):S75-S82.
12. Sheth T., Nair C., Muller J., Yusuf S. Increased winter mortality from acute myocardial infarction and stroke: the effect of age. J Am Coll Cardiol 1999, 33:1916-1919.
13. Douglas A.S., Dunnigan M.G., Allan T.M., Rawles J.M. Seasonal variation in coronary heart disease in Scotland. J Epidemiol Community Health 1995, 49:575-582.
14. Fattman C.L., Schaefer L.M., Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 2003, 35:236-256.
15. Noble M.I., Drake-Holland A.J., Vink H. Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process. QJM 2008, 101:513-518.
16. Broekhuizen L.N., Mooij H.L., Kastelein J.J., Stroes E.S., Vink H., Nieuwdorp M. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Curr Opin Lipidol 2009, 20:57-62.
17. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001, 88:E14-E22.
18. Milne G.L., Yin H., Brooks J.D., Sanchez S., Jackson R.L., Morrow J.D. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Meth Enzymol 2007, 433:113-126.
19. LePard K.J. Choline acetyltransferase and inducible nitric oxide synthase are increased in myenteric plexus of diabetic guinea pig. Auton Neurosci 2005, 118:12-24.
20. Duda M., Konior A., Klemenska E., Beresewicz A. Preconditioning protects endothelium by preventing ET-1-induced activation of NADPH oxidase and xanthine oxidase in post-ischemic heart. J Mol Cell Cardiol 2007, 42:400-410.
21. - and NO generation in the post-ischemic guinea-pig heart. Cardiovasc Res 2004, 63:118-129.
22. Kurzelewski M., Czarnowska E., Beresewicz A. Superoxide- and nitric oxide-derived species mediate endothelial dysfunction, endothelial glycocalyx disruption, and enhanced neutrophil adhesion in the post-ischemic guinea-pig heart. J Physiol Pharmacol 2005, 56:163-178.
23. Wang Z., Ciabattoni G., Creminon C., Lawson J., Fitzgerald G.A., Patrono C., et al. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 1995, 275:94-100.
24. Wood K.M., Cadogan M.D., Ramshaw A.L., Parums D.V. The distribution of adhesion molecules in human atherosclerosis. Histopathology 1993, 22:437-444.
25. Rubio-Gayosso I., Platts S.H., Duling B.R. Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. Am J Physiol 2006, 290:H2247-H2256.
26. Kumagai R., Lu X., Kassab G.S. Role of glycocalyx in flow-induced production of nitric oxide and reactive oxygen species. Free Radic Biol Med 2009, 47:600-607.
27. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ Res 2000, 86:494-501.
28. Wassmann S., Wassmann K., Nickenig G. Regulation of antioxidant and oxidant enzymes in vascular cells and implications for vascular disease. Curr Hypertens Rep 2006, 8:69-78.
29. Berry C.E., Hare J.M. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004, 555:589-606.
30. McNally J.S., Davis M.E., Giddens D.P., Saha A., Hwang J., Dikalov S., et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol 2003, 285:H2290-H2297.
31. Landmesser U., Spiekermann S., Preuss C., Sorrentino S., Fischer D., Manes C., et al. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol 2007, 27:943-948.
32. Jung O., Marklund S.L., Geiger H., Pedrazzini T., Busse R., Brandes R.P. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res 2003, 93:622-629.
33. Gongora M.C., Qin Z., Laude K., Kim H.W., McCann L., Folz J.R., et al. Role of extracellular superoxide dismutase in hypertension. Hypertension 2006, 48:473-481.
34. Landmesser U., Merten R., Spiekermann S., Buttner K., Drexler H., Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2000, 101:2264-2270.
35. Nagareddy P.R., Xia Z., Mcneill J.H., Macleod K.M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol 2005, 289:H2144-H2152.
36. Guzik T.J., Mussa S., Gastaldi D., Sadowski J., Ratnatunga C., Pillai R., et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002, 105:1656-1662.
37. Wendt M.C., Daiber A., Kleschyov A.L., Mulsch A., Sydow K., Schulz E., et al. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med 2005, 39:381-391.
38. Matsumoto S., Koshiishi I., Inoguchi T., Nawata H., Utsumi H. Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic Res 2003, 37:767-772.
39. Oda A., Bannai C., Yamaoka T., Katori T., Matsushima T., Yamashita K. Inactivation of Cu, Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Horm Metab Res 1994, 26:1-4.
40. Quagliaro L., Piconi L., Assaloni R., Da Ros R., Maier A., Zuodar G., et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005, 183:259-267.
41. Nieuwdorp M., Mooij H.L., Kroon J., Atasever B., Spaan J.A., Ince C., et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006, 55:1127-1132.
42. Farhangkhoee H., Khan Z.A., Mukherjee S., Cukiernik M., Barbin Y.P., Karmazyn M., et al. Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol 2003, 35:1439-1448.